Study Evaluating Persistence Of Antibody Response Elicited By 13vPnC In Healthy Adults Previously Vaccinated
Clinical trial NCT01025336 · COMPLETED
Trial details
- NCT number
- NCT01025336
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2010-10-01
- Enrollment
- 962
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.